Is DVHGF or DIVO a better dividend investment in 2026?

DVHGF currently yields 18.78% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: DVHGF offers higher current income.

What is the dividend yield difference between DVHGF and DIVO?

DVHGF has a forward dividend yield of 18.78% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 12.29 percentage points.

Home › Compare › DVHGF vs DIVO

DVHGF vs DIVO: Dividend Comparison 2026

DVHGF yields 18.78% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DVHGF wins by $37.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

DVHGF

● Live price

18.78%

Share price

$10.65

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$67.7K

Annual income

$5,902.75

Full DVHGF calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — DVHGF vs DIVO

📍 DVHGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DVHGF	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DVHGF + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

DVHGF pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DVHGF

Annual income on $10K today (after 15% tax)

$1,596.24/yr

After 10yr DRIP, annual income (after tax)

$5,017.34/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, DVHGF beats the other by $4,182.91/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DVHGF + DIVO for your $10,000?

DVHGF: 50%DIVO: 50%

100% DIVO50/50100% DVHGF

Portfolio after 10yr

$49.2K

Annual income

$3,442.22/yr

Blended yield

6.99%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DVHGF buys

DIVO buys

No recent congressional trades found for DVHGF or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDVHGFDIVO

Forward yield	18.78% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$67.7K ✓	$30.7K
Annual income after 10y	$5,902.75 ✓	$981.68
Total dividends collected	$37.3K ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: DVHGF vs DIVO ($10,000, DRIP)

Year	DVHGF Portfolio	DVHGF Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$12,578	$1,877.93	$11,349	$649.42	+$1.2K → DVHGF
2	$15,666	$2,207.53	$12,833	$688.83	+$2.8K → DVHGF
3	$19,332	$2,569.62	$14,459	$727.90	+$4.9K → DVHGF
4	$23,649	$2,963.53	$16,238	$766.49	+$7.4K → DVHGF
5	$28,692	$3,388.10	$18,179	$804.47	+$10.5K → DVHGF
6	$34,543	$3,841.75	$20,293	$841.71	+$14.3K → DVHGF
7	$41,283	$4,322.49	$22,591	$878.14	+$18.7K → DVHGF
8	$49,001	$4,828.00	$25,087	$913.65	+$23.9K → DVHGF
9	$57,787	$5,355.68	$27,791	$948.18	+$30.0K → DVHGF
10	$67,735	$5,902.75	$30,718	$981.68	+$37.0K → DVHGF

DVHGF vs DIVO: Complete Analysis 2026

DVHGF — Stock

Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, a Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric or duodenal ulcers; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, it acquires drug and health product licenses; and distributes pharmaceutical products. Devonian Health Group Inc. has a strategic alliance with CannTx Life Sciences Inc. for the development of cannabinoid-based pharmaceutical drugs. The company was incorporated in 2015 and is headquartered in Québec, Canada.

Full DVHGF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this DVHGF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DVHGF vs SCHD DVHGF vs JEPI DVHGF vs O DVHGF vs KO DVHGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.